Journal of the Korean Ophthalmological Society

Search

Page Path

HOME
Search

Original Articles

Efficacy of Intravitreal Dexamethasone Implant for Diabetic Macular Edema According to Previous Responses to Bevacizumab.: Doyeon Kim, Dong Geun Park, Gahyung Ryu, Min Sagong; J Korean Ophthalmol Soc. 2020;61(1):51-58. Published online January 15, 2020; DOI: https://doi.org/10.3341/jkos.2020.61.1.51; PDF

Case Reports

Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Secondary to Optic Nerve Head Drusen.: Ka Hee Park; J Korean Ophthalmol Soc. 2019;60(12):1369-1373. Published online December 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.12.1369; PDF

Original Articles

Comparison of Short-term Effects of Intravitreal Injection of Three Modalities on Central Retinal Vein Occlusion.: Ji Seong Jeong, Dong Woo Lee, Byoung Seon Kim, Woong Sun Yoo, In Young Chung, Jong Moon Park; J Korean Ophthalmol Soc. 2019;60(11):1072-1079. Published online November 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.11.1072
Web of Science 1 Crossref 1; PDF

Case Reports

Fulminant Toxoplasmic Chorioretinitis Following Intravitreal Dexamethasone Implantation.: Areum Jeong, Dong Geun Park, Min Sagong; J Korean Ophthalmol Soc. 2019;60(9):896-900. Published online September 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.9.896
Web of Science 1 Crossref 1; PDF

Original Articles

Status of Usage of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration.: Songhee Cho, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):758-764. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.758
Web of Science 2 Crossref 4; PDF

Intravitreal Injection of Anti-vascular Endothelial Growth Factor in Age-related Macular Degeneration: a Systematic Review.: Min Joo Kang, Sang Jin Shin, Jae Kyung Suh et al.; J Korean Ophthalmol Soc. 2019;60(8):748-757. Published online August 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.8.748; PDF

Analysis of Intraocular Pressure Elevation after Intravitreal Injection of Ranibizumab and Aflibercept.: Tae Kyu Moon, Jun Young Ha, Mi Sun Sung, Sang Woo Park; J Korean Ophthalmol Soc. 2019;60(4):362-368. Published online April 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.4.362; PDF

Clinical Changes after Switching from Ranibizumab/Aflibercept to Bevacizumab in Exudative Age-related Macular Degeneration.: In Ho Lee, Jae Jung Lee, Han Jo Kwon, Sung Who Park, Ji Eun Lee; J Korean Ophthalmol Soc. 2019;60(1):40-46. Published online January 15, 2019; DOI: https://doi.org/10.3341/jkos.2019.60.1.40
Web of Science 2 Crossref 4; PDF

Effectiveness of Intravitreal Preservative-free Triamcinolone Injection for Refractory Macular Edema Secondary to Retinal Vein Occlusion.: Chang Hwan Lee, Moo Hwan Jang, Young Seung Seo; J Korean Ophthalmol Soc. 2018;59(8):730-737. Published online August 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.8.730
Crossref 1; PDF

Combined Low Dose Bevacizumab-triamcinolone versus Bevacizumab Single Intravitreal Injection for Branch Retinal Vein Occlusion.: Min Ho Shin, Hyun Ji Kang, Jin Seok Seo, In Young Chung; J Korean Ophthalmol Soc. 2018;59(7):650-656. Published online July 15, 2018; DOI: https://doi.org/10.3341/jkos.2018.59.7.650
Crossref 2; PDF

Efficacy of Primary Intravitreal Ranibizumab Injection for Treatment of Type 1 Retinopathy of Prematurity.: Gyu Chul Chung, Sung Hyuk Moon; J Korean Ophthalmol Soc. 2017;58(9):1080-1086. Published online September 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.9.1080
Crossref 2; PDF

Long-term Efficacy of Vitrectomy for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients Treated with Intravitreal Injections.: In Hwan Cho, Un Chul Park, Hyeong Gon Yu; J Korean Ophthalmol Soc. 2017;58(5):546-553. Published online May 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.5.546; PDF

The Effect of Intravitreal Injection on the Corneal Endothelium.: So Jung Ryu, Yong Un Shin, Min Ho Kang, Mincheol Seong, Hee Yoon Cho; J Korean Ophthalmol Soc. 2017;58(4):401-407. Published online April 15, 2017; DOI: https://doi.org/10.3341/jkos.2017.58.4.401
Crossref 4; PDF

Comparison between Aflibercept, Ranibizumab Intravitreal Injection on Neovascular Age-related Macular Degeneration Patients.: Ji Sang Min, Hyun Chul Jung, Ji Young Suh, Yoon Hyung Kwon; J Korean Ophthalmol Soc. 2016;57(11):1738-1744. Published online November 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.11.1738
Crossref 6; PDF

Relationship between Pain and Injection Site during Intravitreal Injection.: Kyeong Do Jeong, Jung Hoon Kim, Jae Suk Kim, Je Hyung Hwang; J Korean Ophthalmol Soc. 2016;57(6):930-934. Published online June 15, 2016; DOI: https://doi.org/10.3341/jkos.2016.57.6.930
Crossref 2; PDF

Volume 65, No. 4

Journal of
the Korean
Ophthalmological
Society

Print ISSN: 0378-6471
Online ISSN: 2092-9374

Impact Factor

0.1

MOST VIEWED MOST CITED

4,670	Contact Lens-induced Acute Red Eye
6,062	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
2,875	Two Cases of Cataract after COVID-19 mRNA Vaccine Injection
1,816	Clinical Outcomes of ATOS-mediated SmartSight Lenticule Extraction
3,989	Clinical Benefits of Amniotic Membrane Contact Lens

Cited By 3	Clinical Results of Cataract Surgery Using the ARTIS ® PL E Intraocular Lens
Cited By 2	Comparison of Anterior Segment Measurements between Scheimpflug-Placido Camera and New Swept-source Optical Coherence Tomography
Cited By 2	Interocular Difference of Axial Length, Anterior Chamber Depth, Keratometry, Corneal Astigmatism According to Axial Length
Cited By 2	Impact of Social Distancing and Personal Hygiene on the Prevalence of Epidemic Keratoconjunctivitis during the COVID-19 Pandemic
Cited By 2	Clinical Benefits of Amniotic Membrane Contact Lens

Editorial Office: SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520 Fax: +82-2-583-6521 E-mail: kos08@ophthalmology.org

Copyright © 2024 by Korean Ophthalmological Society.

prev

next